MINERAL

MINERAL was reported 1980 times

MINERAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MALIGNANT BOWEL OBSTRUCTION 1 0.0625
1 EPSTEIN-BARR VIRUS ANTIGEN POSITIVE 1 0.0086
2 BASOSQUAMOUS CARCINOMA 1 0.0067
3 THYROGLOBULIN INCREASED 1 0.0059
4 HAEMOGLOBIN 1 0.0050
5 NAIL HYPERTROPHY 1 0.0049
6 PROLONGED EXPIRATION 1 0.0038
7 BLOOD KETONE BODY 1 0.0029
8 ACCELERATED HYPERTENSION 1 0.0026
9 MESENTERIC ARTERY THROMBOSIS 1 0.0026
10 NEUTRALISING ANTIBODIES POSITIVE 1 0.0024
11 INSTILLATION SITE ERYTHEMA 1 0.0019
12 GASTRIC ANTRAL VASCULAR ECTASIA 1 0.0019
13 SYSTEMIC SCLERODERMA 1 0.0014
14 SMALL FIBRE NEUROPATHY 1 0.0014
15 ANAEMIA OF CHRONIC DISEASE 1 0.0011
16 CERUMEN IMPACTION 1 0.0011
17 TELANGIECTASIA 1 0.0010
18 GASTRECTOMY 1 0.0010
19 BENIGN NEOPLASM 1 0.0009
20 HYPOCHLORAEMIA 1 0.0009
21 EMBOLISM ARTERIAL 1 0.0008
22 DEVICE MISUSE 1 0.0008
23 SIALOADENITIS 1 0.0007
24 CYSTITIS INTERSTITIAL 1 0.0006
25 INTESTINAL POLYP 1 0.0006
26 ARTHROPOD STING 1 0.0006
27 BLOOD LOSS ANAEMIA 1 0.0004
28 OXYGEN CONSUMPTION INCREASED 1 0.0004
29 INSTILLATION SITE PAIN 1 0.0004
30 HYPERPARATHYROIDISM SECONDARY 1 0.0004
31 RETINAL ARTERY OCCLUSION 1 0.0004
32 EXCORIATION 1 0.0004
33 STEATORRHOEA 1 0.0004
34 EYELID MARGIN CRUSTING 1 0.0003
35 ANXIETY DISORDER 1 0.0003
36 ONYCHOCLASIS 2 0.0003
37 TACHYPHRENIA 1 0.0003
38 SCLERODERMA 1 0.0003
39 TESTIS CANCER 1 0.0003
40 OBSTRUCTION 1 0.0003
41 TOOTH INJURY 1 0.0002
42 BONE CANCER 1 0.0002
43 NEPHROGENIC ANAEMIA 1 0.0002
44 SKIN TIGHTNESS 1 0.0002
45 MALABSORPTION 1 0.0002
46 JAW DISORDER 1 0.0002
47 HYPERTONIA 1 0.0002
48 VISUAL DISTURBANCE 1 0.0002
49 MOUTH SWELLING 1 0.0002
50 RALES 1 0.0002
51 MUSCLE SPASTICITY 2 0.0002
52 PHOTOPSIA 1 0.0002
53 FOREIGN BODY SENSATION IN EYES 1 0.0002
54 HERPES SIMPLEX 1 0.0002
55 BREAST MASS 1 0.0001
56 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
57 MASS 2 0.0001
58 RIGHT VENTRICULAR FAILURE 1 0.0001
59 BLINDNESS TRANSIENT 1 0.0001
60 GINGIVAL PAIN 1 0.0001
61 DECUBITUS ULCER 1 0.0001
62 ABNORMAL FAECES 1 0.0001
63 PRODUCT CONTAINER ISSUE 1 0.0001
64 MUSCULOSKELETAL DISCOMFORT 2 0.0001
65 BLOOD MAGNESIUM DECREASED 1 0.0001
66 CARDIAC MURMUR 1 0.0001
67 NAIL DISORDER 1 0.0001
68 IRON DEFICIENCY ANAEMIA 1 0.0001
69 RECALLED PRODUCT ADMINISTERED 1 0.0001
70 BODY TEMPERATURE DECREASED 1 0.0001
71 EYE DISCHARGE 1 0.0001
72 WEIGHT FLUCTUATION 1 0.0001
73 TRANSFUSION 1 0.0001
74 SKIN LACERATION 1 0.0001
75 MALNUTRITION 1 0.0001
76 EYE INFECTION 1 0.0001
77 MITRAL VALVE INCOMPETENCE 1 0.0001
78 NEOPLASM 1 0.0001
79 GASTRIC HAEMORRHAGE 1 0.0001
80 SPINAL PAIN 1 0.0001
81 DERMATITIS ALLERGIC 1 0.0001
82 JOINT RANGE OF MOTION DECREASED 1 0.0001
83 BLINDNESS UNILATERAL 1 0.0001
84 PARAESTHESIA ORAL 1 0.0001
85 INJECTION SITE HAEMATOMA 1 0.0001
86 CARDIOMYOPATHY 1 0.0001
87 HYPOAESTHESIA ORAL 1 0.0001
88 SWOLLEN TONGUE 2 0.0001
89 SCIATICA 1 0.0001
90 LOCAL SWELLING 1 0.0001
91 METASTASES TO LIVER 1 0.0001
92 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
93 HEAD DISCOMFORT 1 0.0001
94 THIRST 1 0.0001
95 AGRANULOCYTOSIS 1 0.0001
96 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
97 PERICARDIAL EFFUSION 1 0.0000
98 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
99 ARRHYTHMIA 2 0.0000
100 BLOOD PRESSURE FLUCTUATION 1 0.0000
101 PRESYNCOPE 1 0.0000
102 PNEUMONIA ASPIRATION 1 0.0000
103 SKIN ULCER 1 0.0000
104 RASH GENERALISED 1 0.0000
105 FEAR 1 0.0000
106 FREQUENT BOWEL MOVEMENTS 1 0.0000
107 THROAT TIGHTNESS 1 0.0000
108 HYPONATRAEMIA 2 0.0000
109 MUSCULAR WEAKNESS 4 0.0000
110 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
111 BONE PAIN 2 0.0000
112 ASCITES 1 0.0000
113 BLOOD POTASSIUM DECREASED 1 0.0000
114 APHASIA 1 0.0000
115 CORONARY ARTERY DISEASE 1 0.0000
116 LIMB DISCOMFORT 1 0.0000
117 HEAD INJURY 1 0.0000
118 HIP FRACTURE 1 0.0000
119 NIGHT SWEATS 1 0.0000
120 PRODUCT DOSE OMISSION 2 0.0000
121 HEART RATE INCREASED 3 0.0000
122 EXPIRED PRODUCT ADMINISTERED 1 0.0000
123 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
124 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
125 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
126 MEMORY IMPAIRMENT 4 0.0000
127 HYPOXIA 1 0.0000
128 LYMPHADENOPATHY 1 0.0000
129 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
130 INTESTINAL OBSTRUCTION 1 0.0000
131 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
132 EXTRA DOSE ADMINISTERED 1 0.0000
133 DRY MOUTH 2 0.0000
134 PSORIATIC ARTHROPATHY 1 0.0000
135 OSTEOARTHRITIS 1 0.0000
136 RECTAL HAEMORRHAGE 1 0.0000
137 BALANCE DISORDER 2 0.0000
138 NEPHROLITHIASIS 1 0.0000
139 TINNITUS 1 0.0000
140 COGNITIVE DISORDER 1 0.0000
141 RASH ERYTHEMATOUS 1 0.0000
142 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
143 DRY EYE 1 0.0000
144 AGGRESSION 1 0.0000
145 CELLULITIS 1 0.0000
146 FLUID RETENTION 1 0.0000
147 BLOOD PRESSURE INCREASED 3 0.0000
148 INFLAMMATION 1 0.0000
149 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
150 MUSCULOSKELETAL PAIN 1 0.0000
151 DISTURBANCE IN ATTENTION 1 0.0000
152 RASH PRURITIC 1 0.0000
153 OEDEMA 1 0.0000
154 ARTHROPATHY 1 0.0000
155 NECK PAIN 1 0.0000
156 FLATULENCE 1 0.0000
157 URINARY TRACT INFECTION 3 0.0000
158 PRODUCT SUBSTITUTION ISSUE 1 0.0000
159 DYSPHONIA 1 0.0000
160 NASAL CONGESTION 1 0.0000
161 PAIN IN EXTREMITY 5 0.0000
162 STOMATITIS 1 0.0000
163 VERTIGO 1 0.0000
164 LOSS OF CONSCIOUSNESS 2 0.0000
165 RHINORRHOEA 1 0.0000
166 DEEP VEIN THROMBOSIS 1 0.0000
167 SWELLING FACE 1 0.0000
168 INSOMNIA 4 0.0000
169 DEHYDRATION 2 0.0000
170 NEOPLASM MALIGNANT 1 0.0000
171 PRODUCT QUALITY ISSUE 2 0.0000
172 BURNING SENSATION 1 0.0000
173 HYPERTENSION 3 0.0000
174 INFECTION 2 0.0000
175 CONSTIPATION 3 0.0000
176 RESPIRATORY FAILURE 1 0.0000
177 ASTHENIA 5 0.0000
178 UNEVALUABLE EVENT 1 0.0000
179 CHRONIC KIDNEY DISEASE 1 0.0000
180 HOSPITALISATION 2 0.0000
181 INJECTION SITE HAEMORRHAGE 1 0.0000
182 CARDIAC FAILURE 1 0.0000
183 INFLUENZA LIKE ILLNESS 1 0.0000
184 DRUG DOSE OMISSION 2 0.0000
185 URTICARIA 2 0.0000
186 RENAL IMPAIRMENT 1 0.0000
187 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
188 DEVICE ISSUE 1 0.0000
189 MUSCLE SPASMS 2 0.0000
190 BLOOD GLUCOSE INCREASED 2 0.0000
191 NEUROPATHY PERIPHERAL 1 0.0000
192 FATIGUE 8 0.0000
193 ATRIAL FIBRILLATION 1 0.0000
194 DYSPEPSIA 1 0.0000
195 FLUSHING 1 0.0000
196 PAIN 6 0.0000
197 HAEMOGLOBIN DECREASED 1 0.0000
198 ARTHRALGIA 4 0.0000
199 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
200 FALL 3 0.0000
201 PALPITATIONS 1 0.0000
202 JOINT SWELLING 1 0.0000
203 PRURITUS 3 0.0000
204 HYPERHIDROSIS 1 0.0000
205 DRY SKIN 1 0.0000
206 VISION BLURRED 1 0.0000
207 WEIGHT DECREASED 2 0.0000
208 COUGH 2 0.0000
209 HYPOAESTHESIA 1 0.0000
210 ACUTE KIDNEY INJURY 1 0.0000
211 PERIPHERAL SWELLING 1 0.0000
212 PARAESTHESIA 1 0.0000
213 NAUSEA 5 0.0000
214 DIARRHOEA 4 0.0000
215 CONFUSIONAL STATE 1 0.0000
216 ABDOMINAL DISCOMFORT 1 0.0000
217 MYALGIA 1 0.0000
218 PYREXIA 2 0.0000
219 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
220 NASOPHARYNGITIS 1 0.0000
221 CHEST PAIN 1 0.0000
222 PRODUCT USE ISSUE 1 0.0000
223 DYSPNOEA 3 0.0000
224 ANAEMIA 1 0.0000
225 GAIT DISTURBANCE 1 0.0000
226 HYPOTENSION 1 0.0000
227 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
228 ABDOMINAL PAIN UPPER 1 0.0000
229 DEPRESSION 1 0.0000
230 DIZZINESS 2 0.0000
231 CONDITION AGGRAVATED 1 0.0000
232 HEADACHE 2 0.0000
233 PNEUMONIA 1 0.0000
234 DEATH 2 0.0000
235 RASH 1 0.0000
236 MALAISE 1 0.0000
237 DRUG INEFFECTIVE 3 0.0000
238 OFF LABEL USE 1 0.0000